Skip to main content
. 2020 Jan 8;10(1):42–45. doi: 10.2991/jegh.k.191215.003

Table 2.

Genotype MTBDRsl Ver 2.0 hybridization pattern observed in resistant isolates

Hybridization band(s) observed Rifampicin resistant (N) Isoniazid mono-resistant (N) Total


Newly diagnosed Follow-up Newly diagnosed Follow-up
gyrA gene
gyrA MUT1 25 27 2 4 58
WT/gyrA MUT1 1 3 0 0 4
WT1-, WT2- 1 0 1 2
gyrA MUT2 4 7 0 0 11
WT2- 1 2 1 0 4
WT/gyrA MUT2 1 4 0 0 5
gyrA MUT3A 13 15 2 0 30
gyrA MUT3B 9 12 0 1 22
gyrA MUT3A and MUT3C 0 2 0 0 2
gyrA MUT3B and MUT3D 0 2 0 0 2
gyrA MUT3C 39 87 7 6 139
WT/gyrA MUT3A 0 1 0 0 1
WT/gyrA MUT3B 0 1 0 1 2
WT/gyrA MUT3C 6 6 1 2 15
gyrA MUT3D 0 3 0 0 3
gyrA MUT3B and MUT3C 1 1 0 0 2
gyrA MUT1 and MUT3A 1 1 2
WT3- 2 17 1 0 20
rrs gene
rrs MUT1 3 27 1 1 32
WT/rrs MUT1 2 9 0 1 12
WT/rrs MUT2 2 2 0 0 4
eis gene
eis MUT1 1 7 0 0 8
eis WT2 absent 4 10 1 0 15
WT/eis MUT1 0 1 0 1 2